Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycogen Storage Disease Type II | 18 | 2025 | 24 | 8.480 |
Why?
|
| Respiratory Insufficiency | 10 | 2025 | 155 | 3.940 |
Why?
|
| alpha-Glucosidases | 9 | 2025 | 17 | 3.410 |
Why?
|
| Muscular Dystrophy, Duchenne | 4 | 2025 | 43 | 3.160 |
Why?
|
| Hypoglossal Nerve | 5 | 2024 | 6 | 2.720 |
Why?
|
| Disease Models, Animal | 19 | 2025 | 2087 | 2.620 |
Why?
|
| Spinocerebellar Ataxias | 3 | 2024 | 13 | 2.460 |
Why?
|
| Phrenic Nerve | 6 | 2024 | 8 | 2.170 |
Why?
|
| Genetic Therapy | 12 | 2025 | 744 | 1.940 |
Why?
|
| Enzyme Replacement Therapy | 5 | 2025 | 16 | 1.900 |
Why?
|
| Motor Neurons | 6 | 2023 | 206 | 1.640 |
Why?
|
| Muscle, Skeletal | 8 | 2023 | 678 | 1.580 |
Why?
|
| Neuromuscular Diseases | 3 | 2023 | 23 | 1.570 |
Why?
|
| Dependovirus | 12 | 2022 | 659 | 1.480 |
Why?
|
| Lung Diseases | 3 | 2017 | 166 | 1.410 |
Why?
|
| Respiration | 4 | 2023 | 88 | 1.380 |
Why?
|
| Dystrophin | 4 | 2025 | 35 | 1.340 |
Why?
|
| Amyotrophic Lateral Sclerosis | 6 | 2020 | 477 | 1.300 |
Why?
|
| Glycogen | 9 | 2025 | 47 | 1.290 |
Why?
|
| Mice | 27 | 2025 | 10343 | 1.250 |
Why?
|
| Respiratory Muscles | 3 | 2025 | 10 | 1.200 |
Why?
|
| Animals | 34 | 2025 | 19768 | 1.130 |
Why?
|
| Mice, Transgenic | 6 | 2025 | 1227 | 1.120 |
Why?
|
| Genetic Vectors | 9 | 2022 | 820 | 1.110 |
Why?
|
| Utrophin | 1 | 2025 | 5 | 0.970 |
Why?
|
| Pulmonary Alveoli | 1 | 2025 | 44 | 0.970 |
Why?
|
| Lung Abscess | 1 | 2024 | 7 | 0.940 |
Why?
|
| Gene Transfer Techniques | 3 | 2018 | 307 | 0.930 |
Why?
|
| Diaphragm | 6 | 2025 | 23 | 0.930 |
Why?
|
| Bronchoscopy | 1 | 2024 | 78 | 0.900 |
Why?
|
| Foreign Bodies | 1 | 2024 | 46 | 0.890 |
Why?
|
| Neuromuscular Junction | 5 | 2025 | 83 | 0.810 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 44 | 0.800 |
Why?
|
| Neurology | 1 | 2022 | 35 | 0.800 |
Why?
|
| Muscle, Smooth | 3 | 2021 | 138 | 0.770 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 737 | 0.750 |
Why?
|
| Retinal Degeneration | 1 | 2021 | 28 | 0.740 |
Why?
|
| Nerve Degeneration | 2 | 2023 | 69 | 0.730 |
Why?
|
| Mice, Knockout | 9 | 2025 | 1999 | 0.730 |
Why?
|
| Superoxide Dismutase | 3 | 2017 | 214 | 0.730 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 20 | 0.700 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 122 | 0.670 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 52 | 0.660 |
Why?
|
| Axons | 1 | 2020 | 120 | 0.660 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2019 | 10 | 0.650 |
Why?
|
| Mice, Inbred mdx | 3 | 2025 | 18 | 0.650 |
Why?
|
| Humans | 37 | 2025 | 60132 | 0.650 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2019 | 14 | 0.650 |
Why?
|
| Macroglossia | 1 | 2019 | 1 | 0.640 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 22 | 0.640 |
Why?
|
| Muscular Diseases | 1 | 2019 | 47 | 0.630 |
Why?
|
| Motor Neuron Disease | 1 | 2019 | 29 | 0.630 |
Why?
|
| Phenotype | 3 | 2023 | 1158 | 0.590 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 387 | 0.580 |
Why?
|
| Lung | 3 | 2023 | 842 | 0.580 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 28 | 0.570 |
Why?
|
| Infant, Premature, Diseases | 1 | 2017 | 46 | 0.560 |
Why?
|
| Down Syndrome | 1 | 2017 | 50 | 0.540 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2017 | 63 | 0.510 |
Why?
|
| Respiratory System Agents | 1 | 2015 | 6 | 0.510 |
Why?
|
| Isoxazoles | 1 | 2015 | 14 | 0.500 |
Why?
|
| Long-Term Potentiation | 1 | 2015 | 43 | 0.500 |
Why?
|
| Male | 15 | 2025 | 27971 | 0.500 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 57 | 0.480 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 3218 | 0.470 |
Why?
|
| Hypoxia | 1 | 2015 | 109 | 0.470 |
Why?
|
| Child, Preschool | 5 | 2024 | 1851 | 0.430 |
Why?
|
| Ataxin-7 | 2 | 2024 | 2 | 0.430 |
Why?
|
| Epilepsy | 2 | 2025 | 111 | 0.420 |
Why?
|
| Child | 9 | 2023 | 4336 | 0.410 |
Why?
|
| Gene Targeting | 1 | 2012 | 82 | 0.380 |
Why?
|
| Inhalation Spacers | 1 | 2011 | 1 | 0.380 |
Why?
|
| Referral and Consultation | 1 | 2015 | 409 | 0.380 |
Why?
|
| Androstadienes | 1 | 2011 | 30 | 0.380 |
Why?
|
| Respiratory Function Tests | 3 | 2020 | 165 | 0.370 |
Why?
|
| Bronchitis | 1 | 2011 | 25 | 0.370 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2011 | 30 | 0.370 |
Why?
|
| Parents | 1 | 2015 | 390 | 0.370 |
Why?
|
| Medulla Oblongata | 2 | 2024 | 9 | 0.360 |
Why?
|
| Fontan Procedure | 1 | 2011 | 20 | 0.360 |
Why?
|
| Spinal Cord | 3 | 2024 | 197 | 0.360 |
Why?
|
| Smoking | 1 | 2015 | 835 | 0.340 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 3 | 2025 | 23 | 0.340 |
Why?
|
| Smoking Cessation | 1 | 2015 | 538 | 0.330 |
Why?
|
| Heart Transplantation | 1 | 2011 | 159 | 0.330 |
Why?
|
| Tongue | 2 | 2024 | 17 | 0.280 |
Why?
|
| Gene Expression | 2 | 2019 | 807 | 0.250 |
Why?
|
| Hemiplegia | 2 | 2023 | 6 | 0.240 |
Why?
|
| Female | 10 | 2025 | 31250 | 0.240 |
Why?
|
| Superoxide Dismutase-1 | 3 | 2020 | 136 | 0.230 |
Why?
|
| Receptors, Cholinergic | 1 | 2024 | 22 | 0.230 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2024 | 51 | 0.220 |
Why?
|
| Astrocytes | 1 | 2024 | 116 | 0.220 |
Why?
|
| Drainage | 1 | 2024 | 150 | 0.220 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2023 | 6 | 0.220 |
Why?
|
| Bulbo-Spinal Atrophy, X-Linked | 1 | 2023 | 2 | 0.220 |
Why?
|
| Apnea | 1 | 2023 | 31 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 82 | 0.210 |
Why?
|
| Heart Rate | 1 | 2025 | 308 | 0.210 |
Why?
|
| Transduction, Genetic | 3 | 2022 | 233 | 0.210 |
Why?
|
| Dysarthria | 1 | 2022 | 8 | 0.210 |
Why?
|
| Mutation | 4 | 2025 | 2471 | 0.210 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2023 | 21 | 0.210 |
Why?
|
| Treatment Outcome | 4 | 2020 | 5262 | 0.210 |
Why?
|
| Pulmonary Medicine | 1 | 2023 | 36 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2020 | 620 | 0.200 |
Why?
|
| Asthma | 2 | 2017 | 423 | 0.200 |
Why?
|
| Infant | 2 | 2017 | 1531 | 0.190 |
Why?
|
| Methacholine Chloride | 2 | 2021 | 27 | 0.190 |
Why?
|
| Muscle Relaxation | 1 | 2021 | 25 | 0.180 |
Why?
|
| Adolescent | 3 | 2020 | 5958 | 0.180 |
Why?
|
| Taste | 1 | 2021 | 34 | 0.180 |
Why?
|
| Peptides | 1 | 2024 | 551 | 0.180 |
Why?
|
| Deglutition | 1 | 2020 | 19 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 127 | 0.170 |
Why?
|
| Muscle Contraction | 2 | 2021 | 199 | 0.170 |
Why?
|
| Gene Deletion | 1 | 2021 | 298 | 0.160 |
Why?
|
| Carnitine | 1 | 2019 | 21 | 0.160 |
Why?
|
| Cell Line | 1 | 2023 | 2017 | 0.160 |
Why?
|
| Mice, 129 Strain | 2 | 2016 | 40 | 0.160 |
Why?
|
| Survivors | 1 | 2020 | 148 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 417 | 0.150 |
Why?
|
| Gene Editing | 1 | 2022 | 301 | 0.150 |
Why?
|
| Infant, Newborn | 2 | 2024 | 1315 | 0.150 |
Why?
|
| Liver | 2 | 2019 | 789 | 0.140 |
Why?
|
| Young Adult | 2 | 2020 | 4396 | 0.140 |
Why?
|
| Enzyme Activation | 1 | 2018 | 356 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 203 | 0.140 |
Why?
|
| Potassium Chloride | 1 | 2017 | 15 | 0.140 |
Why?
|
| Pulmonary Emphysema | 1 | 2018 | 87 | 0.140 |
Why?
|
| Albuterol | 1 | 2017 | 20 | 0.140 |
Why?
|
| Extracellular Space | 1 | 2017 | 31 | 0.140 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2018 | 88 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 1481 | 0.140 |
Why?
|
| Bronchi | 1 | 2017 | 79 | 0.140 |
Why?
|
| Trachea | 1 | 2017 | 92 | 0.130 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 304 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 854 | 0.130 |
Why?
|
| Synaptic Potentials | 1 | 2015 | 7 | 0.130 |
Why?
|
| Calcium Signaling | 1 | 2017 | 155 | 0.130 |
Why?
|
| Infant, Premature | 1 | 2017 | 180 | 0.130 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2016 | 75 | 0.130 |
Why?
|
| Brain Stem | 1 | 2015 | 29 | 0.130 |
Why?
|
| Florida | 1 | 2015 | 41 | 0.120 |
Why?
|
| Hotlines | 1 | 2015 | 22 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 96 | 0.120 |
Why?
|
| Quality of Life | 1 | 2022 | 1140 | 0.120 |
Why?
|
| Intention | 1 | 2015 | 66 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2015 | 108 | 0.110 |
Why?
|
| Myofibrils | 1 | 2013 | 19 | 0.110 |
Why?
|
| Prognosis | 1 | 2018 | 1591 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 157 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 69 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 130 | 0.110 |
Why?
|
| Motor Activity | 1 | 2015 | 343 | 0.100 |
Why?
|
| Caregivers | 1 | 2015 | 232 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2015 | 745 | 0.100 |
Why?
|
| Metered Dose Inhalers | 1 | 2011 | 5 | 0.100 |
Why?
|
| Fluticasone | 1 | 2011 | 13 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 193 | 0.090 |
Why?
|
| Sputum | 1 | 2011 | 36 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 669 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 120 | 0.090 |
Why?
|
| Azithromycin | 1 | 2011 | 27 | 0.090 |
Why?
|
| Heart | 1 | 2013 | 276 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 661 | 0.090 |
Why?
|
| Adult | 2 | 2020 | 15985 | 0.090 |
Why?
|
| Risk Factors | 2 | 2017 | 5082 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 400 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 96 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 290 | 0.080 |
Why?
|
| Cough | 1 | 2011 | 183 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 1471 | 0.060 |
Why?
|
| Myasthenic Syndromes, Congenital | 1 | 2024 | 2 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2025 | 138 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2025 | 306 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2023 | 28 | 0.050 |
Why?
|
| Protein Domains | 1 | 2024 | 141 | 0.050 |
Why?
|
| Cell Communication | 1 | 2023 | 127 | 0.050 |
Why?
|
| Seizures | 1 | 2023 | 118 | 0.050 |
Why?
|
| Macaca | 1 | 2022 | 30 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2025 | 527 | 0.050 |
Why?
|
| Swine | 1 | 2022 | 349 | 0.050 |
Why?
|
| Stem Cells | 1 | 2023 | 258 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2023 | 376 | 0.050 |
Why?
|
| Respiratory System | 1 | 2021 | 42 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 93 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 422 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 570 | 0.040 |
Why?
|
| Middle Aged | 1 | 2015 | 16535 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 1313 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 712 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 2016 | 17 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2016 | 8 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2016 | 9 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 36 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2016 | 34 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2016 | 53 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 86 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 230 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2016 | 104 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 110 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1213 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 102 | 0.030 |
Why?
|
| Pediatrics | 1 | 2017 | 268 | 0.030 |
Why?
|
| Tibia | 1 | 2014 | 70 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 281 | 0.030 |
Why?
|
| Pleura | 1 | 2013 | 12 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 379 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 197 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 630 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 1054 | 0.020 |
Why?
|
| Myocardium | 1 | 2013 | 263 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1040 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 2479 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 443 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 6139 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 13581 | 0.020 |
Why?
|